Upregulation of the STAT1/NOS2 pathway has not been reported in HI before; however, it has been described in other inflammatory skin diseases, such as psoriasis and atopic dermatitis (26, 32), sharing characteristics of skin barrier impairment and increased inflammation. This evidence concerns the gene NOS2 and atopic eczema.